If you have a lesion or other persistent symptoms that might point to vulvar cancer, ask your doctor for a biopsy so you can rule out cancer.
If you have already been diagnosed, see a specialist: an oncologist trained and certified specifically in gynecologic cancers.
At Holden Comprehensive Cancer Center at the University of Iowa, our highly experienced physicians and staff are dedicated to taking care of you, not just your cancer. As part of a nationally recognized cancer center, our clinicians are also top researchers, finding new and innovative treatments and therapies.
The vulva is the female external genitalia and entryway to the vagina. Vulvar cancer is highly treatable, because regular annual exams will normally find the cancer in its earliest stages.
Vulvar cancer is relatively rare, and it usually develops slowly over a period of years. The vulva is essentially epithelial skin so the main tumor types that affect this area are skin-related cancers.
Holden Comprehensive Cancer Center is the only institution in Iowa to hold the prestigious designation of being a Comprehensive Cancer Center by the National Cancer Institute (NCI), meaning we are rated in the top 4 percent of the approximately 1,500 cancer centers in the United States. A recent study published in the journal Cancer showed that patients treated at NCI-designated cancer centers have better survival outcomes than patients treated at non–NCI-designated cancer centers.
To be considered a "comprehensive" center means our teams have expertise in clinical, laboratory, and population-based research. Our doctors and staff are on top of the newest developments in cancer research, treatment, and diagnosis.
Clinical trials is where research meets patient care. A great deal of research is done behind the scenes in laboratories, long before clinical trials can even begin.
Clinical trials are research studies that test out the latest treatments and drugs that are not yet available to the wider public. These new treatments have the potential to improve your quality of life or increase your chances of survival.
See a full list and learn more about clinical trials at Holden Comprehensive Cancer Center.
We bring experts from different fields of medicine to work together as a team called a multidisciplinary oncology group (MOG). Because many patients require more than one form of treatment, our team meets regularly to discuss the best course of treatment and works together to design the best personalized plan for every patient.